All entries for: Roivant Sciences Ltd.

February 6, 2026

Roivant Sciences Ltd.

Negative Outlook

New York, NY
501-1,000 employees

Over time, the IRA could increase our government discount and rebate liabilities, reduce the revenues we are able to collect from sales of our products as well as present challenges for payor negotiations and formulary access. However, the degree of impact that the IRA will ultimately have upon our business remains unclear at this time.

Disease Area: Oncology
Drug Type: Small Molecule
Scroll to Top